Attached files
| file | filename |
|---|---|
| EX-10.16 - FORM OF SECURITIES PURCHASE AGREEMENT ENTERED INTO BY AND BETWEEN THE COMPANY AN - ABVC BIOPHARMA, INC. | f10k2019ex10-16_americanbriv.htm |
| EX-32.1 - CERTIFICATION - ABVC BIOPHARMA, INC. | f10k2019ex32-1_americanbriv.htm |
| EX-31.2 - CERTIFICATION - ABVC BIOPHARMA, INC. | f10k2019ex31-2_americanbriv.htm |
| EX-31.1 - CERTIFICATION - ABVC BIOPHARMA, INC. | f10k2019ex31-1_americanbriv.htm |
| EX-23.1 - CONSENT OF KCCW ACCOUNTANCY CORP - ABVC BIOPHARMA, INC. | f10k2019ex23-1_americanbriv.htm |
| EX-10.15 - FORM OF SECURITIES PURCHASE AGREEMENT ENTERED INTO BY AND BETWEEN THE COMPANY AN - ABVC BIOPHARMA, INC. | f10k2019ex10-15_americanbriv.htm |
| EX-10.9 - EMPLOYMENT AGREEMENT WITH CHIHLIANG AN - ABVC BIOPHARMA, INC. | f10k2019ex10-9_americanbriv.htm |
| 10-K - ANNUAL REPORT - ABVC BIOPHARMA, INC. | f10k2019_americanbriv.htm |
Exhibit 32.2
Certification Pursuant To
Section 906 of Sarbanes-Oxley Act of 2002
I, Chihliang An, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:
| 1. | The Annual Report on Form 10-K for the year ended December 31, 2019 of American BriVision (Holding) Corporation (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (U.S.C. 78m or 78o(d)); and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: May 15, 2020 | By: | /s/ Chihliang An |
| Chihliang An | ||
Chief Financial Officer (Principal Financial and Accounting Officer) |
The foregoing certification is being furnished solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of a separate disclosure document.